抗N-甲基嘌呤DNA糖基化酶(MPG)多克隆抗體
Anti-N-Methylpurine DNA Glycosylase (MPG) Polyclonal Antibody
AAG; APNG; ADPG; CRA36.1; MDG; Mid1; PIG11; PIG16; Anpg; DNA-3-Methyladenine Glycosylase; Alkyladenine DNA Glycosylase; 3-alkyladenine DNA glycosylase
- 編號FAH625Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 激發(fā)波長
- 單次使用量
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 且適物種-
- 應用Flow cytometry.
- 下載 英文說明書 中文說明書
- 規(guī)格 25test50test 100test 200test 500test
- 價格 暫無報價 暫無報價 暫無報價 暫無報價 暫無報價
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Human Hela cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 20μg/ml rabbit Anti-human MPG Polyclonal Antibody (Catalog FAH625Hu01, red histogram) or Isotype control antibody (Catalog IS067-Rb01, green histogram), followed by 1μg/ml FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
用法
Flow cytometry: 20μg/ml;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過一年。避免反復凍融。
贈品
增值服務
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPH625Hu01 | N-甲基嘌呤DNA糖基化酶(MPG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAH625Hu01 | N-甲基嘌呤DNA糖基化酶(MPG)多克隆抗體 | WB; ICC; IHC-P; IHC-F; ELISA. |
| FAH625Hu01 | 抗N-甲基嘌呤DNA糖基化酶(MPG)多克隆抗體 | Flow cytometry. |
| MAH625Hu21 | N-甲基嘌呤DNA糖基化酶(MPG)單克隆抗體 | WB; IHC; ICC; IP. |
| SEH625Hu | N-甲基嘌呤DNA糖基化酶(MPG)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMH625Hu | N-甲基嘌呤DNA糖基化酶(MPG)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Journal of Vascular Surgery | Circulation levels of acute phase proteins in patients with Takayasu arteritis [PubMed: 20100644] |
| PLoS One | Effect of MPG Gene rs2858056 Polymorphism, Copy Number Variation, and Level of Serum MPG Protein on the Risk for Rheumatoid Arthritis [PubMed: 25757089] |
| Translational?Oncology | OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth [Pubmed: 30468988] |
留言咨詢
